Plymouth medical device company HistoSonics raises $100M : v

HistoSonics recently submitted safety and efficacy data from its liver cancer treatment clinical trials to the Food and Drug Administration and expects market authorization in 2023.

Related Keywords

Minnesota , United States , California , Wisconsin , Ann Arbor , Michigan , , Signature Bank , Varian Medical Systems , Drug Administration , Johnson , University Of Michigan , Fred Moll , Intuitive Surgical , Venture Investors , Wisconsin Investment , Medical Alley , Mike Blue ,